根据美国Frost ＆ Sullivan（F&S）公司市场情报室最新报告,1993年西欧免疫治疗市场为18亿美元,1998年将翻一番。迄今,最大的免疫治疗市场是免疫系统抑制剂（1993年欧洲销售额为75100万美元）,其次是疫苗（46400万美元）、细胞因子（30800万美元）和球蛋白制品（24200万美元）。 单克隆抗体目前尚未上市。F&S公司估计,到1998年单克隆抗体销售额将达到4亿美元。免疫抑制剂将仍占有最大市场,1998年其销售额可达19亿美元,其次为疫苗,略超过10 According to the latest report of the market intelligence office of Frost & Sullivan (F&S) in the United States, the immunotherapy market in western Europe was 1.8 billion U.S. dollars in 1993 and will double in 1998. To date, the largest market for immunotherapy has been the immune system inhibitor (Europe’s sales of US$ 751 million in 1993), followed by vaccines (US$ 464 million), cytokines (US$ 308 million), and globulin products (US$ 242 million). Monoclonal antibodies are not currently available. F&S estimates that sales of monoclonal antibodies will reach 400 million U.S. dollars by 1998. Immunosuppressive drugs will still occupy the largest market, with sales of up to $1.9 billion in 1998, followed by vaccines, slightly over 10%